author-photo

Bijal D. Shah

University of South Florida

233

Papers

2029

Citations

Citation Trend

Filter By

Papers (155) Sort By

Journal Conference Others

Primary Progression on Frontline Therapy for Diffuse Large B-Cell Lymphoma Is Associated with a Poor Outcome Despite Subsequent CD19 Targeted CAR T-Cell Therapy

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Impact of total body irradiation based myeloablative conditioning regimen in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant: systematic review and meta-analysis.

2021
Show All
- Source
- Cite
- Save
Citations (1)
Change in Patients' Perceived Cognition Among Chimeric Antigen Receptor T-Cell Therapy Recipients at Day 360

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real World Experience from the US Lymphoma CAR T Consortium

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy.

2021 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (1)
A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Preliminary safety and efficacy of PBCAR0191, an allogeneic, off-the-shelf CD19-targeting CAR-T product, in relapsed/refractory (r/r) CD19+ NHL.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Real-World Bruton Tyrosine Kinase Inhibitor Treatment Patterns, Compliance, Costs, and Hospitalizations in Patients with Mantle Cell Lymphoma in the United States

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion Is Highly Active in Patients with Relapsed/Refractory B-Cell Malignancies

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)